Co-Authors
This is a "connection" page, showing publications co-authored by Boris Pasche and Clancy Clark.
Connection Strength
0.222
-
Alistar A, Morris BB, Desnoyer R, Klepin HD, Hosseinzadeh K, Clark C, Cameron A, Leyendecker J, D'Agostino R, Topaloglu U, Boteju LW, Boteju AR, Shorr R, Zachar Z, Bingham PM, Ahmed T, Crane S, Shah R, Migliano JJ, Pardee TS, Miller L, Hawkins G, Jin G, Zhang W, Pasche B. Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial. Lancet Oncol. 2017 06; 18(6):770-778.
Score: 0.173
-
Enomoto LM, Fenstermaker J, Desnoyers RJ, Pasche BC, Blackstock AW, Howerton RM, Clark CJ, Levine EA, Shen P. Oncology Navigation Decreases Time to Treatment in Patients with Pancreatic Malignancy. Ann Surg Oncol. 2019 May; 26(5):1512-1518.
Score: 0.049